Aberrant activation of the complement system has been widely recognized as a major pathogenic factor in the development of LN, with increasing attention focused on the terminal complement component 5a (C5a) and complement component 5a receptor (C5aR1) in recent years.8 The gene discussed is C5AR1; the disease is lobular neoplasia.